In this sense, the proliferative effect promoted by oxLDL/LOX-1 has been described in muscle cells, endothelial cells and recently in breast cancer cells through activation pathways that involve p38 (MAPK), p44/42 MAPK, and NF- kB [6], [39]. This evidence concerns the gene OLR1 and breast cancer.